About Heron Therapeutics
Heron Therapeutics is a company based in Redwood City (United States) founded in 1983. It operates as a Direct-to-Consumer (D2C). Heron Therapeutics has raised $32.14 million across 10 funding rounds from investors including Hercules Capital, Rubric Capital and Velan Capital. The company has 122 employees as of December 31, 2024. Heron Therapeutics offers products and services including SUSTOL, CINVANTI, ZYNRELEF, and APONVIE. Heron Therapeutics operates in a competitive market with competitors including Jazz Pharmaceuticals, C4 Therapeutics, Erasca, MiRagen and Mereo BioPharma, among others.
- Headquarter Redwood City, United States
- Employees 122 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Heron Therapeutics, Inc.
-
Annual Revenue
$144.28 M13.57as on Dec 31, 2024
-
Net Profit
$-13.58 M87.72as on Dec 31, 2024
-
EBITDA
$-9.04 M91.61as on Dec 31, 2024
-
Total Equity Funding
$32.14 M (USD)
in 10 rounds
-
Latest Funding Round
$30 M (USD), Post-IPO
Jul 24, 2023
-
Investors
Hercules Capital
& 6 more
-
Employee Count
122
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Heron Therapeutics
Heron Therapeutics is a publicly listed company on the NASDAQ with ticker symbol HRTX in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Heron Therapeutics
Heron Therapeutics offers a comprehensive portfolio of products and services, including SUSTOL, CINVANTI, ZYNRELEF, and APONVIE. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Used for preventing chemotherapy-induced nausea and vomiting.
Administered to prevent nausea and vomiting from chemotherapy.
Designed for managing postoperative pain in patients.
Utilized for preventing postoperative nausea and vomiting.
Unlock access to complete
Unlock access to complete
Software Development Team
29 people
Leadership Team
24 people
Sales and Marketing
8 people
Finance and Accounting
4 people
Operations Team
3 people
Legal and Compliance
3 people
Human Resources and Administration
2 people
Senior Team
2 people
Unlock access to complete
Funding Insights of Heron Therapeutics
Heron Therapeutics has successfully raised a total of $32.14M across 10 strategic funding rounds. The most recent funding activity was a Post-IPO round of $30 million completed in July 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 10
- Last Round Post-IPO — $30.0M
-
First Round
First Round
(04 Nov 2009)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2023 | Amount | Post-IPO - Heron Therapeutics | Valuation |
investors |
|
| Aug, 2022 | Amount | Post-IPO - Heron Therapeutics | Valuation |
investors |
|
| May, 2021 | Amount | Post-IPO - Heron Therapeutics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Heron Therapeutics
Heron Therapeutics has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include Hercules Capital, Rubric Capital and Velan Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Clearline Capital, LLC is engaged in emerging market debt solutions.
|
Founded Year | Domain | Location | |
|
Venture debt financing is provided to companies in multiple sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Heron Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Heron Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Heron Therapeutics Comparisons
Competitors of Heron Therapeutics
Heron Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, C4 Therapeutics, Erasca, MiRagen and Mereo BioPharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Small-molecule drugs for cancer treatment are developed via Degronimid platform.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
MicroRNA-based therapeutics are developed for treating multiple diseases.
|
|
| domain | founded_year | HQ Location |
Therapeutics for cancer and rare diseases are developed.
|
|
| domain | founded_year | HQ Location |
Targeted therapeutics for cancer, metabolic, and inflammatory diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Heron Therapeutics
Frequently Asked Questions about Heron Therapeutics
When was Heron Therapeutics founded?
Heron Therapeutics was founded in 1983 and raised its 1st funding round 26 years after it was founded.
Where is Heron Therapeutics located?
Heron Therapeutics is headquartered in Redwood City, United States. It is registered at Redwood City, California, United States.
Is Heron Therapeutics a funded company?
Heron Therapeutics is a funded company, having raised a total of $32.14M across 10 funding rounds to date. The company's 1st funding round was a Post-IPO of $150M, raised on Nov 04, 2009.
How many employees does Heron Therapeutics have?
As of Dec 31, 2024, the latest employee count at Heron Therapeutics is 122.
What is the annual revenue of Heron Therapeutics?
Annual revenue of Heron Therapeutics is $144.28M as on Dec 31, 2024.
What does Heron Therapeutics do?
Heron Therapeutics is dedicated to advancing therapeutic standards for patients through innovative science and technologies. The company is engaged in developing and commercializing a portfolio of best-in-class therapies aimed at addressing unmet medical needs in acute care and oncology sectors. Solutions such as SUSTOL, CINVANTI, ZYNRELEF, and APONVIE are provided to prevent issues like chemotherapy-induced nausea, vomiting, and postoperative pain. The focus is placed on improving patient outcomes by rethinking treatment approaches and reducing reliance on opioids in surgical settings.
Who are the top competitors of Heron Therapeutics?
Heron Therapeutics's top competitors include Jazz Pharmaceuticals, C4 Therapeutics and Erasca.
What products or services does Heron Therapeutics offer?
Heron Therapeutics offers SUSTOL, CINVANTI, ZYNRELEF, and APONVIE.
Is Heron Therapeutics publicly traded?
Yes, Heron Therapeutics is publicly traded on NASDAQ under the ticker symbol HRTX.
Who are Heron Therapeutics's investors?
Heron Therapeutics has 7 investors. Key investors include Hercules Capital, Rubric Capital, Velan Capital, Clearline Capital, and Deep Track Capital.
What is Heron Therapeutics's ticker symbol?
The ticker symbol of Heron Therapeutics is HRTX on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.